BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260501
DTSTAMP:20260530T195344
CREATED:20260327T142423Z
LAST-MODIFIED:20260327T142423Z
UID:10109-1777248000-1777593599@thebiocalendar.com
SUMMARY:BPI Europe
DESCRIPTION:Join us as we return to Vienna\, a globally recognized meeting destination and one of Europe’s premier life science hubs. The city is home to the renowned Vienna BioCenter\, a nexus of academic research and over 50 innovative biotech companies\, alongside industry leaders like Boehringer Ingelheim\, Takeda and Novartis. This powerful combination of scientific excellence\, seamless accessibility\, and rich cultural heritage provides the ideal backdrop to connect with global pioneers and forge the collaborations that will drive the future of bioprocessing.
URL:https://thebiocalendar.com/event/bpi-europe/
LOCATION:Vienna\, Vienna\, 1300\, Austria
CATEGORIES:Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260530T195344
CREATED:20251209T120633Z
LAST-MODIFIED:20251209T120633Z
UID:9639-1777334400-1777507199@thebiocalendar.com
SUMMARY:Cell & Gene Therapy Summit
DESCRIPTION:A Decade of Expertise\, Now in China: Cell & Gene Therapy Summit 2026 \n\n\n\nWith over a decade of experience hosting premier cell and gene therapy events in the US and Europe\, attracting 1\,500+ attendees annually\, Cell & Gene Therapy International is bringing its expertise to China. The 2026 summit in Shanghai is designed to foster collaboration among top researchers\, biopharmaceutical leaders\, and industry pioneers\, with a focus on cutting-edge R&D\, manufacturing excellence\, and strategic partnerships. Attendees will gain unparalleled insights into breakthrough methodologies across cell therapies\, gene editing platforms\, viral vector technologies\, and the discovery-to-clinic continuum—empowering them to drive innovation and growth in the China market.
URL:https://thebiocalendar.com/event/cell-gene-therapy-summit/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260530T195344
CREATED:20251210T120316Z
LAST-MODIFIED:20251210T120316Z
UID:9640-1777334400-1777507199@thebiocalendar.com
SUMMARY:ChinaBio Partnering Forum
DESCRIPTION:The ChinaBio Partnering Forum is China’s premier life science event\, connecting global biopharma with China’s market for strategic partnerships\, investment\, and innovation\, featuring partneringONE technology\, company pitches (like Startup Spotlight)\, expert panels\, and networking to accelerate cross-border deals.
URL:https://thebiocalendar.com/event/chinabio-partnering-forum-3/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Forum,Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260501
DTSTAMP:20260530T195344
CREATED:20260130T130200Z
LAST-MODIFIED:20260202T184211Z
UID:9838-1777334400-1777593599@thebiocalendar.com
SUMMARY:3rd Biophysics for Drug Discovery Summit 
DESCRIPTION:The 3rd Biophysics for Drug Discovery Summit offers a rare\, highly technical\, industry-focused forum dedicated solely to biophysics. Unlike broader drug discovery meetings\, this summit provides a comprehensive view of techniques\, emerging technologies\, and practical applications. Through case studies\, panel discussions\, and interactive dialogue\, attendees will explore how next-generation biophysics drives predictive pipelines and accelerates discovery.  \nTo find out more\, please view the full 2026 event program here: https://ter.li/efenue
URL:https://thebiocalendar.com/event/3rd-biophysics-for-drug-discovery-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T110000
DTEND;TZID=America/Los_Angeles:20260429T120000
DTSTAMP:20260530T195344
CREATED:20260327T123222Z
LAST-MODIFIED:20260327T123222Z
UID:10100-1777460400-1777464000@thebiocalendar.com
SUMMARY:Driving Smarter Chemistry in Drug Discovery: Using Full DEL Data to Improve Early Compound Decisions
DESCRIPTION:Modern screening approaches generate rich datasets that capture how large collections of compounds interact with biological targets. However\, discovery teams often rely on only a small portion of that information when selecting compounds for synthesis\, potentially missing important signals across the broader dataset. \nIn this webinar\, we explore how evaluating the full screening landscape can reveal structure–function insight across related compounds. This approach helps guide more informed chemistry decisions. By looking beyond individual hits\, scientists can better understand which chemical series merit further investment and which should be deprioritized earlier in the program. \nKey Learning Objectives:\n– How evaluating the full DEL screening dataset can reveal meaningful patterns across related compounds\, not just individual enriched binders\n– Why examining structure–function trends across chemical series can improve confidence in early synthesis decisions\n– How a more complete view of DEL data can help discovery teams prioritize the right series and reduce downstream risk
URL:https://thebiocalendar.com/event/driving-smarter-chemistry-in-drug-discovery-using-full-del-data-to-improve-early-compound-decisions/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-29-26-XChem-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T110000
DTEND;TZID=America/Los_Angeles:20260429T120000
DTSTAMP:20260530T195344
CREATED:20260407T114850Z
LAST-MODIFIED:20260407T114850Z
UID:10134-1777460400-1777464000@thebiocalendar.com
SUMMARY:Execution Without Direction: The Hidden Risk in Outsourced Clinical Trials
DESCRIPTION:As clinical trials become increasingly outsourced\, a critical gap has emerged between sponsor expectations and CRO execution. Many smaller biotech companies rely heavily on outsourcing vendors to drive their programs\, often without the internal clinical operations infrastructure needed to provide direction\, oversight\, and strategic alignment. \nAt the same time\, vendor teams—particularly CRAs—are frequently stretched thin and charged with executing small tasks without understanding the bigger picture. The result is a growing disconnect: between sponsors and CROs\, CRAs and sites\, and protocols and real-world operations. These gaps can lead to inefficiencies\, risks\, and strained site relationships that ultimately impact study success. \nIn this live webinar\, industry experts will explore the root causes of this disconnect and examine whether clinical oversight monitors are a necessary evolution\, or an added layer of complexity. Through real-world insights and practical examples\, we’ll discuss how organizations can better align stakeholders\, improve trial execution\, and close the widening operational gap. \nIn this webinar\, you will:\n– Understand the structural gaps that commonly exist between sponsors\, CROs\, and clinical sites\n– Learn why traditional CRO models may fall short in providing strategic clinical oversight\n– Identify the risks and inefficiencies that arise from fragmented clinical operations\n– Explore the role of oversight functions in improving alignment\, quality\, and site relationships\n– Gain practical strategies for strengthening collaboration and ensuring more cohesive trial execution
URL:https://thebiocalendar.com/event/execution-without-direction-the-hidden-risk-in-outsourced-clinical-trials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-29-26-ISG-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T130000
DTEND;TZID=America/Los_Angeles:20260429T140000
DTSTAMP:20260530T195344
CREATED:20260323T180943Z
LAST-MODIFIED:20260323T180943Z
UID:10055-1777467600-1777471200@thebiocalendar.com
SUMMARY:How Connected Manufacturing Operations Unlock AI's Potential to Optimize Production
DESCRIPTION:Research findings from 150 manufacturing leaders uncovered a “connectivity crisis” preventing production optimization. This webinar addresses the imperative to break down the silos today that are creating the delays\, rework\, and compliance issues that 90%-plus manufacturers struggle with. Start at the bottom and build the connected data foundation that makes AI actually work.
URL:https://thebiocalendar.com/event/how-connected-manufacturing-operations-unlock-ais-potential-to-optimize-production/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-29-26-MasterControl-Reg-1920x250-1.png
END:VEVENT
END:VCALENDAR